Vulvovaginal atrophy in the CRETA study: the healthcare professionals' perception.

María J CanceloRafael Sánchez BorregoSantiago PalaciosLaura BaquedanoTanit Corbacho GarzaNoelia Fernández AllerCarmen García FerreiroJuan José Quijano MartínA Javier González Calvo

Published in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2023)

Spanish gynecologists are in general agreement with their patients regarding VVA treatment preferences and the main issues for adherence and effectiveness. However, there is an opportunity for doctor-patient communication improvement. Among the three therapeutic options evaluated, ospemifene is regarded as offering some competitive advantages.

Keyphrases

end stage renal disease
randomized controlled trial
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
case report
adipose tissue
metabolic syndrome
patient reported outcomes
skeletal muscle